X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 58 filers reported holding X4 PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 5.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,500 | -31.7% | 241,744 | +21.6% | 0.00% | – |
| Q2 2023 | $385,757 | +481.8% | 198,844 | +160.9% | 0.00% | – |
| Q1 2023 | $66,299 | -12.2% | 76,205 | +0.2% | 0.00% | – |
| Q4 2022 | $75,524 | -22.1% | 76,057 | +32.9% | 0.00% | – |
| Q3 2022 | $97,000 | +3133.3% | 57,237 | +1701.6% | 0.00% | – |
| Q2 2022 | $3,000 | -81.2% | 3,177 | -64.3% | 0.00% | – |
| Q1 2022 | $16,000 | -40.7% | 8,909 | -26.1% | 0.00% | – |
| Q4 2021 | $27,000 | -41.3% | 12,058 | +37.0% | 0.00% | – |
| Q3 2021 | $46,000 | -31.3% | 8,800 | -14.1% | 0.00% | – |
| Q2 2021 | $67,000 | +148.1% | 10,242 | +227.8% | 0.00% | – |
| Q1 2021 | $27,000 | -81.0% | 3,124 | -85.8% | 0.00% | – |
| Q4 2020 | $142,000 | +24.6% | 22,068 | +31.1% | 0.00% | – |
| Q3 2020 | $114,000 | -43.6% | 16,834 | -22.5% | 0.00% | – |
| Q2 2020 | $202,000 | +392.7% | 21,708 | +435.5% | 0.00% | – |
| Q1 2020 | $41,000 | -80.1% | 4,054 | -79.0% | 0.00% | – |
| Q4 2019 | $206,000 | +148.2% | 19,290 | +195.9% | 0.00% | – |
| Q3 2019 | $83,000 | +66.0% | 6,519 | +92.9% | 0.00% | – |
| Q2 2019 | $50,000 | +525.0% | 3,379 | +584.0% | 0.00% | – |
| Q1 2019 | $8,000 | – | 494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |